Literature DB >> 21553018

Development of POEMS syndrome after an initial manifestation of solitary plasmacytoma.

Motohiro Shindo1, Kazuya Sato2, Masayo Yamamoto1, Yasumichi Toki1, Mayumi Hatayama1, Satoshi Ito1, Kazuhiko Ichiki1, Naoka Okamura1, Takaaki Hosoki1, Katsuya Ikuta1, Junki Inamura3, Shinji Watanabe3, Yoshihiro Torimoto4, Yutaka Kohgo1.   

Abstract

A 44-year-old male was admitted for numbness in the left arm. CT showed a tumor impacting on the spinal cord with an adjacent thoracic vertebral osteosclerotic lesion. The histopathology of the tumor showed diffuse proliferation of atypical plasma cells with expressed vascular endothelial growth factor (VEGF), which is a known etiological factor in POEMS syndrome. Though serum VEGF (sVEGF) level was elevated, a diagnosis of solitary plasmacytoma with an osteosclerotic lesion was made as the patient presented no polyneuropathy, organomegaly, endocrinopathy, or skin changes. The patient experienced muscle weakness of the lower limbs and skin pigmentation/hemangioma one year after irradiation of the osteosclerotic lesion. Laboratory tests revealed hypothyroidism, hyperglycemia, serum monoclonal gammopathy, further elevation of sVEGF, and increased atypical bone marrow plasma cells. CT imaging showed splenomegaly, and a nerve conduction test revealed demyelinating motor peripheral neuropathy. The patient was therefore diagnosed with POEMS syndrome. Plasmacytoma is very rare as an initial manifestation of POEMS syndrome. Patients presenting with plasmacytoma with an osteosclerotic lesion should be carefully observed and evaluated for the expression of sVEGF and development of POEMS syndrome, as most bone plasmacytomas in POEMS syndrome patients are reported to be osteosclerotic. This is to our knowledge the first case of osteosclerotic plasmacytoma that progressed to POEMS syndrome, with an increase of sVEGF.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21553018     DOI: 10.1007/s12185-011-0863-2

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.490


  35 in total

1.  An autopsy case of Crow-Fukase syndrome which developed 18 years after the first manifestation of plasmacytoma.

Authors:  H Sakemi; H Okada
Journal:  Intern Med       Date:  1992-01       Impact factor: 1.271

2.  POEMS syndrome: definitions and long-term outcome.

Authors:  Angela Dispenzieri; Robert A Kyle; Martha Q Lacy; S Vincent Rajkumar; Terry M Therneau; Dirk R Larson; Philip R Greipp; Thomas E Witzig; Rita Basu; Guillermo A Suarez; Rafael Fonseca; John A Lust; Morie A Gertz
Journal:  Blood       Date:  2002-11-27       Impact factor: 22.113

3.  Vascular endothelial growth factor and interleukin-6 in paracrine tumor-stromal cell interactions in multiple myeloma.

Authors:  B Dankbar; T Padró; R Leo; B Feldmann; M Kropff; R M Mesters; H Serve; W E Berdel; J Kienast
Journal:  Blood       Date:  2000-04-15       Impact factor: 22.113

Review 4.  Multiple myeloma associated with diffuse osteosclerotic bone lesions: a clinical entity distinct from osteosclerotic myeloma (POEMS syndrome).

Authors:  M Q Lacy; M A Gertz; C A Hanson; D J Inwards; R A Kyle
Journal:  Am J Hematol       Date:  1997-12       Impact factor: 10.047

5.  [Successful treatment of POEMS syndrome with high-dose chemotherapy and autologous peripheral blood stem cell transplantation].

Authors:  Kazue Takai; Koji Niikuni; Tori Kurasaki
Journal:  Rinsho Ketsueki       Date:  2004-10

6.  Successful hematopoietic stem-cell transplantation in multicentric Castleman disease complicated by POEMS syndrome.

Authors:  Apar Kishor Ganti; Iraklis Pipinos; Eliad Culcea; James O Armitage; Stefano Tarantolo
Journal:  Am J Hematol       Date:  2005-07       Impact factor: 10.047

7.  Solitary myeloma: clinical and prognostic features of a review of 114 cases.

Authors:  R Bataille; J Sany
Journal:  Cancer       Date:  1981-08-01       Impact factor: 6.860

Review 8.  POEMS syndrome.

Authors:  Angela Dispenzieri
Journal:  Blood Rev       Date:  2007-09-11       Impact factor: 8.250

9.  Plasma cell dyscrasia with polyneuropathy, organomegaly, endocrinopathy, M protein, and skin changes: the POEMS syndrome. Report on two cases and a review of the literature.

Authors:  P A Bardwick; N J Zvaifler; G N Gill; D Newman; G D Greenway; D L Resnick
Journal:  Medicine (Baltimore)       Date:  1980-07       Impact factor: 1.889

Review 10.  Treatment of POEMS syndrome.

Authors:  Angela Dispenzieri; Morie A Gertz
Journal:  Curr Treat Options Oncol       Date:  2004-06
View more
  1 in total

1.  Successful treatment of POEMS syndrome with bortezomib and dexamethasone, combined with radiotherapy, and followed by autologous stem cell transplantation.

Authors:  Yoshimi Ishii; Etsuko Yamazaki; Yasufumi Ishiyama; Eri Yamamoto; Yukako Hattori; Maki Hagihara; Naoto Tomita; Yoshiaki Ishigatsubo
Journal:  Int J Hematol       Date:  2013-10-29       Impact factor: 2.490

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.